News & Media

  • All
  • AI Technology
  • Business News
  • Clinical Trials
  • Diabetic Screening
  • Eye Health
42PLUS1 US Satellite Award 768 512 Toku Eyes
  • Toku Eyes

42PLUS1 US Satellite Award

Happy to announce the winner of the 42PLUS1 US Satellite Award! Congratulations Toku Eyes! 🚀🚀🚀 What a great innovation you shared at the DxPx Conference stage about the artificial intelligence…

read more
On a mission to democratize eyecare, Toku Eyes takes its technology to the U.S. 768 512 Toku Eyes
  • Toku Eyes

On a mission to democratize eyecare, Toku Eyes takes its technology to the U.S.

The company uses AI to detect eye health, as well as diabetes and cardiovascular conditions There are 43 million people in the world who are blind, and another 295 million who have…

read more
NZ-based AI firm launches tool to assess heart risk through retinal scans in U.S. 768 512 Toku Eyes
  • Toku Eyes

NZ-based AI firm launches tool to assess heart risk through retinal scans in U.S.

Toku Eyes, a New Zealand-based healthcare AI company, is launching its tool that assesses heart risk through a retinal scan in the U.S. The tool, called ORAiCLE, uses an AI…

read more
Kiwi AI tool launches in India 768 512 Toku Eyes
  • Toku Eyes

Kiwi AI tool launches in India

An Artificial Intelligence retinal screening tool, developed in New Zealand, is being used in 20 eye clinics in India and is about to launch in the United States. THEIA has…

read more
New Zealand tech company develops tool to detect diseases like diabetes 768 512 Toku Eyes
  • Toku Eyes

New Zealand tech company develops tool to detect diseases like diabetes

Around 280,000 New Zealanders have diabetes, with the disease almost three times more common in Māori than non-Māori. And mortality rates for the disease are nine times higher for Māori…

read more
An easier way to detect diabetes through technology 768 512 Toku Eyes
  • Toku Eyes

An easier way to detect diabetes through technology

Detecting diabetes is about to get a whole lot easier. A Kiwi company has created a revolutionary technology called THEIA, which uses AI to examine blood vessels in the eye…

read more
AI tool detects early signs of eye disease 1024 683 Toku Eyes
  • Toku Eyes

AI tool detects early signs of eye disease

The trial of an Artificial Intelligence retinal screening tool, developed in New Zealand, showed it did not miss any referable disease for diabetic patients at risk of eye disorders. THEIA…

read more
Advice from a clear-sighted entrepreneur 1024 683 Toku Eyes
  • Toku Eyes

Advice from a clear-sighted entrepreneur

Ehsan Vaghefi has been a guide all his life. After all, when other children his age were being helped across the street by their parents, he was helping his blind…

read more
A New Zealand startup using AI to detect eye disease raises $3.35 million 1024 683 Toku Eyes
  • Toku Eyes

A New Zealand startup using AI to detect eye disease raises $3.35 million

New Zealand startup Toku Eyes, which has built an artificial intelligence platform to improve early detection of eye diseases such as macular degeneration, glaucoma and other diseases observable via the…

read more
Top scores for Kiwi AI screening tool 1024 683 Toku Eyes
  • Toku Eyes

Top scores for Kiwi AI screening tool

Toku Eyes has completed its first prospective clinical trial of its artificial intelligence (AI) screening platform Theia, designed to support more cost-effective diagnosis and prognosis of eye disorders. The trial,…

read more
Toku Eyes raises millions for AI Tech that helps stop diabetes, preventable blindness 1024 683 Toku Eyes
  • Toku Eyes

Toku Eyes raises millions for AI Tech that helps stop diabetes, preventable blindness

Auckland startup Toku Eyes has raised $3.6 million to develop its AI software – which founder Dr Ehsan Vaghefi says can analyse eye images faster than a human clinician and…

read more
A multi-center prospective evaluation of THEIA 1024 683 Toku Eyes
  • Toku Eyes

A multi-center prospective evaluation of THEIA

A multi-center prospective evaluation of THEIA to detect diabetic retinopathy (DR) and diabetic macular edema (DME) in the New Zealand screening program Purpose: to assess the efficacy of THEIA, an…

read more

Ask us about your health screening requirements

    Dr. Ehsan Vaghefi, CEO

    Launching impactful clinical solutions for real world health issues

    © Toku Eyes 2022 | All rights reserved

    Enter your
    text here